| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 57,943 | 50,053 | 58,908 | 49,967 | | Cost of Revenue | 36,272 | 31,142 | 39,217 | 31,733 | | | Gross Profit | 21,671 | 18,911 | 19,691 | 18,234 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,090 | 16,709 | 16,357 | 13,542 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,581 | 2,202 | 3,334 | 4,692 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 896 | 1,460 | 358 | 488 | | Earnings Before Interest And Taxes | 5,477 | 3,662 | 3,692 | 5,180 | | Interest Expense | 1 | 2 | 23 | 17 | | Income Before Tax | 5,476 | 3,660 | 3,669 | 5,163 | | Income Tax Expense | 1,877 | 1,165 | 1,310 | 1,662 | | Minority Interest | (404) | (145) | 145 |
-
| | | | Net Income From Continuing Ops | 3,195 | 2,350 | 2,504 | 3,501 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,195 | 2,350 | 2,504 | 3,501 | | Preferred Stock And Other Adjustments | 164 | (164) |
-
|
-
| | | Net Income Applicable To Common Shares | $3,359 | $2,186 | $2,504 | $3,501 |
|
0.03% Nasdaq 
0.41%
Income Statement
